The European CBD Report: Health & Wellness has been published by Prohibition Partners and sponsored by Atalis.Â
The companies have stated the LOI positions each to take advantage of potential German adult use legalisation within their respective supply chain verticals.Â
The restructuring initiative is expected to save the company USD$7 million by the end of 2023.
Linnea will begin producing GMP-certified high-THC APIs in 2023.
The UK-based pharmaceutical company has stated that the registration follows seven harvests and extractions and an MHRA inspection in 2022.
Ambrani CBD is expanding its distribution to the continent with a focus on brick-and-mortar retail in Germany.
Flora Growth has provided an update to its international commercial cannabis export business.
The application has been submitted in preparation for a review.
French cannabis industry representatives have welcomed the news, stating the industry will now be able to flourish in the country.
The country has confirmed it intends to produce cannabis products domestically.
We won’t spam you
© 2023 Prohibition Holdings Ltd. All Rights Reserved.
